HAE prophylactic drug pricing concerns for approved drugs | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  9520 of 12405  at  2/6/2019 5:44:45 PM  by

lysander_us

The following message was updated on 2/6/2019 5:48:15 PM.

 In response to msg 9519 by  map.here
view thread

Re: HAE prophylactic drug pricing concerns for approved drugs

  
 Good article map, thanks for posting.
 
How can Takeda (Shire) NOT be nervous about BCRX taking a healthy chunk of business away from them and NOT be looking at an offer to protect/consolidate their market and investment in DYAX? 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 223
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.
Loading...